Herpes Zoster and Diabetes Mellitus: A Review
- PMID: 29520743
- PMCID: PMC6104256
- DOI: 10.1007/s13300-018-0394-4
Herpes Zoster and Diabetes Mellitus: A Review
Abstract
Accumulating evidence suggests that diabetes mellitus (DM) represents an important risk factor for both herpes zoster and post-herpetic neuralgia. Moreover, post-herpetic neuralgia appears to be more severe and persistent in diabetic patients. On the other hand, a novel vaccine against varicella-zoster virus (VZV) was recently introduced in clinical practice. Given the increased risk and severity of herpes zoster infection in patients with DM, this vaccine might be useful in this population. However, there are limited data regarding the efficacy and safety of vaccination against herpes zoster in the diabetic population. The aim of the present review is to discuss the incidence and consequences of herpes zoster infection in DM and to comment on the role of vaccination against VZV in these patients.
Keywords: Adjuvanted vaccine; Diabetes mellitus; Herpes zoster; Live attenuated vaccine; Post-herpetic neuralgia; Vaccination.
Similar articles
-
[Vaccines against varicella-zoster virus (VZV)].Enferm Infecc Microbiol Clin. 2015 Jun-Jul;33(6):411-23. doi: 10.1016/j.eimc.2015.05.005. Epub 2015 Jun 19. Enferm Infecc Microbiol Clin. 2015. PMID: 26096575 Spanish.
-
Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity.Herpes. 2007 Sep;14 Suppl 2:45-7. Herpes. 2007. PMID: 17939896 Review.
-
Efficacy of varicella (VZV) vaccination: an update for the clinician.Ther Adv Vaccines. 2016 Jan;4(1-2):20-31. doi: 10.1177/2051013616655980. Epub 2016 Jan 1. Ther Adv Vaccines. 2016. PMID: 27551429 Free PMC article.
-
Prevention of shingles by varicella zoster virus vaccination.Expert Rev Vaccines. 2006 Aug;5(4):431-43. doi: 10.1586/14760584.5.4.431. Expert Rev Vaccines. 2006. PMID: 16989624 Review.
-
Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention.Expert Rev Vaccines. 2018 Jul;17(7):619-634. doi: 10.1080/14760584.2018.1495565. Epub 2018 Jul 20. Expert Rev Vaccines. 2018. PMID: 30028651 Review.
Cited by
-
The diabetes pandemic and associated infections: suggestions for clinical microbiology.Rev Med Microbiol. 2019 Jan;30(1):1-17. doi: 10.1097/MRM.0000000000000155. Epub 2018 Nov 1. Rev Med Microbiol. 2019. PMID: 30662163 Free PMC article.
-
Cerebrovascular events after herpes zoster infection: a risk that should be not underestimated.J Neurovirol. 2019 Aug;25(4):439-447. doi: 10.1007/s13365-019-00748-9. Epub 2019 May 8. J Neurovirol. 2019. PMID: 31069708 Review.
-
Efficacy and effectiveness of Herpes zoster vaccination in adults with diabetes mellitus: a systematic review and meta-analysis of clinical trials and observational studies.Acta Diabetol. 2023 Oct;60(10):1343-1349. doi: 10.1007/s00592-023-02127-7. Epub 2023 Jun 20. Acta Diabetol. 2023. PMID: 37340183 Free PMC article.
-
Causal effect of body mass index on herpes zoster and postherpetic neuralgia: A Mendelian randomization study.Medicine (Baltimore). 2025 Jun 6;104(23):e42775. doi: 10.1097/MD.0000000000042775. Medicine (Baltimore). 2025. PMID: 40489821 Free PMC article.
-
Vaccinome Landscape in Nearly 620 000 Patients With Diabetes.J Clin Endocrinol Metab. 2025 Apr 22;110(5):e1590-e1597. doi: 10.1210/clinem/dgae476. J Clin Endocrinol Metab. 2025. PMID: 39040010 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources